Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections.
Yue FeiJianbing WuHong-Wei AnKai ZhuBo PengJunquan CaiYihua ZhangYunzhu LiHao WangZhangjian HuangPublished in: Journal of medicinal chemistry (2020)
Implantable medical device-related infections with biofilms have become a significant challenge in clinics. Based on the potential bacteria biofilm dispersing effect of nitric oxide (NO) and the unique antibacterial activity of antimicrobial peptides (AMP), we synthesized five peptides and selected the most potent one to conjugate its N-terminal with a furoxan moiety to offer a hitherto unknown NO-donating antimicrobial peptide (FOTyr-AMP), which exhibited Staphylococcus aureus and Escherichia coli biofilm dispersion and eradication, and potent antibacterial activities in vitro. In an implanted biofilm infection mice model, topical subcutaneous injection of FOTyr-AMP allowed synergetic eradication of bacterial biofilms and potent antibacterial activity, superior to the antibiotic cephalosporin C. Given the low hemolysis effect, little influence on the blood pressure, and potent in vivo efficacy of FOTyr-AMP, it is clear that subcutaneous administration of FOTyr-AMP could be a promising approach for the intervention of medical device-related biofilm infections with desirable safety.
Keyphrases
- staphylococcus aureus
- candida albicans
- protein kinase
- pseudomonas aeruginosa
- biofilm formation
- nitric oxide
- anti inflammatory
- escherichia coli
- blood pressure
- randomized controlled trial
- silver nanoparticles
- healthcare
- helicobacter pylori infection
- cystic fibrosis
- primary care
- hydrogen peroxide
- nitric oxide synthase
- metabolic syndrome
- risk assessment
- type diabetes
- amino acid
- climate change
- multidrug resistant
- helicobacter pylori
- human health
- gram negative